Skip to main content
SpringerLink
Log in

Negativer PgR-Status: kein gutes Omen

  • Gynäkoonkologie
  • Literatur kompakt
  • Published:
Im Focus Onkologie Aims and scope

Patientinnen mit Östrogenrezeptor-positivem und Progesteronrezeptor-negativem Mammakarzinom sprechen besser auf eine neoadjuvante Therapie an als Frauen mit PgR-positivem Tumor. Dennoch ist ihre Prognose schlechter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Van Mackelenbergh MT et al. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials. Breast Cancer Res Treat. 2018;167(1):59–71.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Robert Bublak

Authors
  1. Robert Bublak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bublak, R. Negativer PgR-Status: kein gutes Omen. Im Focus Onkologie 21, 51–52 (2018). https://doi.org/10.1007/s15015-018-3842-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-018-3842-0

Search

Navigation